Latest Articles & Resources FEATURED FDA Opens PreCheck Program for Domestic Manufacturing Read More » FDA Opens PreCheck Program for Domestic Manufacturing Read More » LATEST NEWS + INTERVIEWS Shilpa Medicare Enters Binding Agreement with NXI Therapeutics AG for Autoimmune NCE Development Ampersand Capital Partners Acquires Purna Pharmaceuticals to Expand Life Sciences Portfolio Altasciences Appoints Marie-Hélène Raigneau as CEO and Names Chris Perkin to Board WuXi Vaccines Achieves ANVISA GMP Approval for DP17 Site in Suzhou Syngene International Partners with Johns Hopkins University to Advance Early-Stage Drug Discovery Rottendorf Pharma Forms Strategic Alliance with Corealis Pharma to De-Risk OSD Scale-Up FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biopharmaceutical CDMO Facility Axplora Inaugurates 4,000 sqm Production Block at Vizag API Site Douglas Pharmaceuticals Appoints Sean Westbrook as Chief Executive Officer Experic Appoints Matthew Mollan as Chief Executive Officer Kincell Bio Partners with RegCell to Advance Treg Cell Therapy Toward Clinical Trials Made Scientific Launches Exclusive Early Adopter Programme with Streamline Bio AsymBio Establishes Integrated Biopharmaceutical CDMO Platforms Across Full Development Lifecycle Fresenius Kabi Partners with Phlow to Onshore U.S. Epinephrine Injection Manufacturing How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for Capacity Constraints – Dr. Reza Oliyai SGS CDMO Solutions to Launch Digital Transparency Platform WuXi Biologics Earns EcoVadis Platinum Medal for Third Consecutive Year Samsung Biologics Validates Product Carbon Footprint System With DNV Scaling Exosome Manufacturing: Lonza’s Strategy for Emerging Modalities TrumpRx Launches: Will Direct-to-Consumer Platform Actually Lower Drug Costs? Scarab Genomics Signs Exclusive Clean Genome Licensing Deal With Bionova PODCAST INTERVIEWS How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for Capacity Constraints – Dr. Reza Oliyai SGS CDMO Solutions to Launch Digital Transparency Platform 2026 US Pharma Outsourcing: Gil Roth on FDA Cuts, Pricing Pressures and CDMO Strategy
How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for Capacity Constraints – Dr. Reza Oliyai
How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for Capacity Constraints – Dr. Reza Oliyai
